Latest News Releases From The Newsroom
US Coast Guard Launches Highest Level of Investigation into Titan Submersible Loss
June 25th, 2023
The U.S. Coast Guard said it has initiated a Marine Board of Investigation (MBI) following the tragic incident involving the Titan submersible and its five occupants. The crew of the Polar Prince research vessel lost communication with the Titan subm. Read more
Market Outlook: EXAS, PCOR, GAMB, GENI, NEE, VVV - Unveiling Potential Upsides
June 25th, 2023
Exact Sciences Corporation (Nasdaq: EXAS) was maintained with a Buy rating by Canaccord Genuity, who raised the price target from $92 to $115. On Friday, $EXAS closed at $92.62, indicating a potential upside of $22.38 or 24.16% based on the . Read more
Lilly's Tirzepatide: A Potential Game-Changer in Diabetes Weight Management
June 25th, 2023
The results from a phase 3 clinical trial evaluating Eli Lilly and Company's (NYSE: LLY) tirzepatide (10 mg and 15 mg) for chronic weight management in individuals with obesity or overweight and type 2 diabetes demonstrated superior weight reduction . Read more
Expected Earnings Figures: BlackBerry, Franklin Covey, and American Outdoor Brands
June 25th, 2023
Several companies are expected to report their financial results on Wednesday, June 28, including: BlackBerry Limited (NYSE: BB), a global leader in secure communication and software solutions, is scheduled to release its first-quarter fiscal year. Read more
DexCom Boosts Outlook; Analysts Bullish on Chipotle, Clean Harbors, and Roivant
June 25th, 2023
DexCom, Inc. (Nasdaq: DXCM) is making significant strides in its financial performance, leading the company to update its year-end 2025 revenue targets. With strong performance in the first two years of the target period, DexCom now expects to achiev. Read more
FDA OKs Pfizer's Spot Baldness Treatment; Analysts PT Boost Sarepta and Darden Restaurants
June 25th, 2023
Pfizer Inc. (NYSE: PFE) has received FDA approval for LITFULO (ritlecitinib), an oral treatment for severe alopecia areata in individuals aged 12 and above. LITFULO, which is expected to be available in the coming weeks, is the first and only FDA-app. Read more
Breaking: FDA's Psychedelic Drug Trials Draft Guidance Revealed
June 24th, 2023
The U.S. Food and Drug Administration (FDA) has released its first draft guidance on conducting clinical trials with psychedelic drugs for potential medical treatment. Published on June 23, 2023, the guidance aims to provide researchers with importan. Read more
Upcoming Key Date: Micron, General Mills, Concentrix, H.B. Fuller, UniFirst
June 24th, 2023
Several companies are scheduled to report their financial results on Wednesday, June 28, including: Micron Technology, Inc. (Nasdaq: MU), a leading semiconductor company, is scheduled to report its third-quarter fiscal 2023 financial results after. Read more
Meta Platforms, ODP, iSun, Affirm, and GitLab - Insights from Market Experts
June 24th, 2023
Meta Platforms, Inc. (Nasdaq: META), a prominent social media company, had its price target raised from $255 to $315 by Roth MKM, maintaining its Buy rating. With Friday's closing price at $288.73, the adjusted price target implies a potenti. Read more
Earnings: Walgreens, TD SYNNEX, Korn Ferry, AeroVironment Financial Figures Expected
June 24th, 2023
On Tuesday, June 27, several companies are expected to report their financial results. Here are some details Walgreens Boots Alliance, Inc. (Nasdaq: WBA), a leading pharmacy retail company, is set to announce its fiscal 2023 third-quarter results . Read more
Want To Find Some News?
News By Industries
Recent Posts
-
A Preview: Oracle, Franco-Nevada, and Asana Earnings Due
March 09th, 2025NVIDIA, Salesforce, and Agilent Technologies Earnings Loom: What to Expect
February 23rd, 2025Key Reports Ahead: KBR, Hims & Hers Health, and Cleveland-Cliffs Earnings Preview
February 23rd, 2025Earnings On Deck: What to Expect from Copart, Cheniere Energy, and Insulet
February 16th, 2025
Member Login